A genus of Gram-negative, obligate anaerobic, sulfate-reducing bacteria (SRB) that produces hydrogen sulfide (H2S) as its primary metabolic end-product. H2S is a potent cytotoxin that disrupts colonocyte energy metabolism, damages the gut barrier, and promotes chronic inflammation. Desulfovibrio enrichment is associated with multiple disease states including endometriosis, cardiovascular disease, parkinsons disease, and cancer.
H2S Production and Toxicity
- Desulfovibrio uses sulfate as a terminal electron acceptor in anaerobic respiration, reducing it to H2S via dissimilatory sulfate reduction.
- H2S toxicity mechanisms in the gut:
- Cytochrome c oxidase inhibition: H2S blocks the terminal enzyme of colonocyte mitochondrial oxidative phosphorylation, starving epithelial cells of energy -- analogous to cyanide poisoning at the cellular level.
- Barrier disruption: energy-depleted colonocytes lose tight junction integrity, increasing gut permeability and enabling bacterial translocation.
- DNA damage: H2S generates reactive sulfur species and free radicals that cause genotoxic damage to colonocytes, contributing to colorectal cancer initiation.
- NF-kB activation: H2S activates NF-kB inflammatory signaling in epithelial and immune cells, driving chronic inflammation.
- H2S competes with butyrate for colonocyte energy metabolism: when H2S levels rise and butyrate levels fall (due to depletion of roseburia, faecalibacterium prausnitzii), colonocytes shift from oxidative to glycolytic metabolism, further destabilizing the anaerobic gut environment.
Metal Dependencies
- Iron: Iron-sulfur clusters are central to the dissimilatory sulfate reduction pathway. Desulfovibrio requires substantial iron for its [Fe]-hydrogenase and ferredoxin electron carriers.
- Nickel: Some species possess [NiFe]-hydrogenase for hydrogen-dependent sulfate reduction, linking their metabolism to nickel availability in the gut.
- Molybdenum: Certain sulfate reductases use molybdenum cofactors.
- Mercury: Desulfovibrio species are enriched by mercury exposure in the gut, and some SRB can methylate inorganic mercury to neurotoxic methylmercury [rezazadegan 2025 heavy metals gut microbiota systematic review].
Disease Associations
- Endometriosis: H2S/NF-kB pathway activation promotes endometrial inflammation and lesion progression. Desulfovibrio enrichment may contribute to the inflammatory milieu driving endometriosis.
- Cardiovascular disease: enriched in CVD; H2S can promote atherosclerotic plaque instability. Spermidine supplementation paradoxically increases Desulfovibrionaceae while improving cardiovascular outcomes, suggesting dose-dependent or context-dependent H2S effects [almeida 2023 gut microbiota cardiovascular axis].
- Colorectal cancer: H2S-mediated DNA damage and NF-kB activation contribute to carcinogenesis. Desulfovibrio showed opposite directionality -- increased in cancer, decreased in autoimmune disease [islam 2022 opposing microbiome signatures autoimmune cancer].
- Parkinson's disease: enriched in PD gut; H2S may compound mitochondrial dysfunction in the enteric nervous system.
- Bilophila wadsworthia (related SRB): metabolizes taurine-conjugated bile acids to produce H2S, linking high-fat diet (which increases taurine-conjugated bile acids) to sulfide-driven inflammation.
H2S as a Double-Edged Sword
- At physiological concentrations, H2S is a gasotransmitter with anti-inflammatory and cytoprotective effects (similar to NO and CO).
- At supraphysiological concentrations produced by Desulfovibrio overgrowth, H2S becomes cytotoxic and pro-inflammatory.
- This dose-response relationship complicates therapeutic targeting: complete elimination of SRB would remove physiological H2S signaling.
Key Metabolites
- Hydrogen sulfide (H2S) -- primary output; cytochrome c oxidase inhibitor, DNA damaging agent, NF-kB activator.
- Acetate -- secondary fermentation product from incomplete oxidation of organic substrates.
- Methylmercury -- some species convert inorganic Hg to neurotoxic MeHg.
Connections
- endometriosis -- H2S/NF-kB pathway activation drives endometrial inflammation
- cardiovascular disease -- enriched in CVD; H2S affects plaque stability
- colorectal cancer -- H2S genotoxicity and cancer-specific enrichment
- parkinsons disease -- enriched in PD; mitochondrial dysfunction via H2S
- iron -- Fe-S clusters central to sulfate reduction metabolism
- nickel -- [NiFe]-hydrogenase in some species
- mercury -- methylation of inorganic Hg to neurotoxic MeHg
- molybdenum -- Mo-cofactor in sulfate reductases
- oxidative stress -- reactive sulfur species drive oxidative DNA damage
- inflammation -- H2S activates NF-kB; chronic inflammatory signaling
- dysbiosis -- enrichment signals sulfidogenic dysbiosis
- ferroptosis -- iron-dependent metabolism may intersect with ferroptotic pathways
- gut metal microbiome -- metal-dependent metabolism; enriched by mercury exposure
- faecalibacterium prausnitzii -- inversely correlated; butyrate vs H2S competition for colonocyte energy